Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Advancing Amyloid Imaging

  • You have access
    Role of partial volume correction in paired studies of C-11 PiB vs F-18 florbetapir: implications for centiloid?
    Dean Wong, Olivier Rousset, Ayon Nandi, Michael Pontecorvo, Kelly Kitzmiller, Paul Rosenberg, Josh Roberts, Noble George, James Brasic, Wael Marashdeh, Lorena Gapasin and Mark Schmidt
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 486;
  • You have access
    Stratifying the mortality risk of patients with cognitive impairment using PIB and FDG PET.
    Johannes Fostitsch, Lars Frings, Martin Boeker, Sabine Hellwig, Tobias Bormann and Philipp Meyer
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 481;
  • You have access
    Correlation of Amyloid PET in Centiloid units with neuropathological findings in Alzheimer’s disease
    Christopher Rowe, Sanka Amadoru, Vincent Dore, Catriona McLean, Fairley Hinton, Claire Shepherd, Glenda Halliday, Cristian Leyton, John Hodges, Colin Masters and Victor Villemagne
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 482;
  • You have access
    Non-negative matrix factorization evaluation of patterns of brain Aβ deposition in Parkinson’s disease, Alzheimer’s disease and normal controls on [18F]florbetapir PET
    Yin Chen, Aristeidis Sotiras, Ilya Nasrallah, Rizwan Akhtar, Jacqueline Rick, Alice Chen-Plotkin, John Trojanowski, Daniel Weintraub, Christos Davatzikos and Jacob Dubroff
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 484;
  • You have access
    Higher amyloid deposition in the striatum in very early-onset Alzheimer's disease: a PIB-PET study
    Liping Fu, Xi Sun, Cuibai Wei, Baixuan Xu and Jiahe Tian
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 478;
  • You have access
    Comparing Amyloid PET Tracers and Interpretation Strategies: First Results from the CAPTAINs Study
    Gerard Bischof, Peter Bartenstein, Henryk Barthel, Bart Van Berckel, Vincent Dore, Thilo Van Eimeren, Norman Foster, Jochen Hammes, Adriaan Lammertsma, Satoshi Minoshima, Christopher Rowe, Osama Sabri, John Seibyl, Koen Van Laere, Rik Vandenberghe, Victor Villemagne, Igor Yakushev and Alexander Drzezga
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 485;
  • You have access
    Clinical impact of F-18 Flutemetamol (FMM) PET to assess cerebral Aß pathology in patients with various cognitive disorders.
    Naoya Hattori, Shogo Ono, NIKI UDO, Shin Yamamoto, Mikako Ogawa and Hiroki Sugie
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 480;
  • You have access
    Differences in regional cerebral glucose metabolism pattern according to amyloid accumulation in depressed patients with MCI: SPM analysis
    Eun Seong Lee, HyunChul Youn, Suji Lee, Hyun Ghang Jeong and Jae Seon Eo
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 479;
  • You have access
    Revising the amyloid buildup curve in Alzheimer’s disease? - Partial volume effect correction of longitudinal amyloid PET data
    Michael Rullmann, Anke McLeod, Michel Grothe, Osama Sabri and Henryk Barthel
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 483;
SNMMI

© 2025 SNMMI

Powered by HighWire